Buying a single share of tech giant Google will set you back a not inconsiderable $1386.32.
H.C.
Canaccord analyst John Newman is out with a bullish note on shares of Palatin Technologies, Inc. (NYSEAMERICAN:PTN), as the drug maker just released it’s fiscal …
John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.
PTN focusing on entering the EU market through partnerships, says analyst.
Canaccord analyst John Newman was out pounding the table on shares of Palatin Technologies, Inc.(NYSEMKT:PTN), reiterating a Buy rating an price target of $6.
Palatin Technologies, Inc. (NYSEMKT:PTN) is circling up to be one of the market’s most undervalued and underestimated stocks this year, and could very …
